Richard Kim

Richard Kim

Co-Principal Investigator


Research Focus:
  • Active Surveillance
  • Research Methods
  • Knowledge Translation/Implementation Science
  • Clinical Therapeutics
  • Other. Biosciences, Personalized Medicine, Pharmacogenomics, and Drug Transport and Metabolism.
  • Professor and Chair, Division of Clinical Pharmacology, Department of Medicine, The University of Western Ontario

Selected Research Projects or Publications:

Dr. Kim received his medical degree from University of Saskatchewan, Canada in 1987. After completing an internship and residency training at Royal University hospital in Saskatoon Canada in 1991, he went on to carry out postdoctoral fellowship training in Clinical Pharmacology at Vanderbilt University.
In 1994, upon completion of his fellowship training, he remained at Vanderbilt Clinical Pharmacology as a faculty member until 2006. He is currently Professor and Chair of the Division of Clinical Pharmacology in the Department of Medicine at the University of Western Ontario in London, Canada. His research interest is that of understanding the molecular basis of interindividual differences in drug disposition and the application of such finding to the emerging field of Personalized Medicine.
Research areas under active investigation in his laboratory include that of drug transporters, CYP enzymes, and the pathways involved in the regulated expression of such proteins. He is a member of ASCPT, ISSX, and AAPS. He is an editor for the Medical Letter Handbook of Adverse Drug Interactions, and an associate editor for Molecular Pharmacology. He is a fellow of AAPS, and member of the American Society for Clinical Investigation (ASCI).